NPM1 and acute myeloid leukemia: Avrainvillamide was more active against NPM1-mutated than wild-type AML cells [36], probably due to the unfolded structure of the C-terminus three-helix bundle, and caused proteasomal degradation of NPM1 mutant and differentiation of OCI-AML3 cells [36].